Docoh
Loading...

VXRT Vaxart

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Company profile

Ticker
VXRT
Exchange
Website
CEO
Andrei Floroiu
Employees
Incorporated
Location
Fiscal year end
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI /DE/, NABI BIOPHARMACEUTICALS, NORTH AMERICAN BIOLOGICALS INC
SEC CIK
IRS number
591212264

VXRT stock data

(
)

Calendar

6 May 21
31 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Jun 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Vaxart earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 157.31M 157.31M 157.31M 157.31M 157.31M 157.31M
Cash burn (monthly) (positive/no burn) (positive/no burn) 5.17M 3.75M 5.53M 3.09M
Cash used (since last report) n/a n/a 20.75M 15.05M 22.2M 12.42M
Cash remaining n/a n/a 136.56M 142.26M 135.11M 144.89M
Runway (months of cash) n/a n/a 26.4 37.9 24.4 46.8

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
19 Jul 21 Echerd Margaret Common Stock Sell Dispose S No Yes 8 1,800 14.4K 0
19 Jul 21 Echerd Margaret Common Stock Option exercise Aquire M No No 0.77 1,467 1.13K 1,800
19 Jul 21 Echerd Margaret Common Stock Option exercise Aquire M No No 5.17 333 1.72K 333
19 Jul 21 Echerd Margaret Stock Option Common stock Option exercise Dispose M No No 0.77 1,467 1.13K 32,287
19 Jul 21 Echerd Margaret Stock Option Common stock Option exercise Dispose M No No 5.17 333 1.72K 3,000
18 Jun 21 Finney Michael J. Common Stock Aquire X No No 1.1 181,818 200K 656,090
18 Jun 21 Finney Michael J. Common Stock Option exercise Aquire M No No 0.68 12,700 8.64K 474,272
18 Jun 21 Finney Michael J. Common Stock Option exercise Aquire M No No 0.68 9,000 6.12K 461,572
18 Jun 21 Finney Michael J. Common Stock Purchase Warrant Common stock Dispose X No No 1.1 181,818 200K 0
18 Jun 21 Finney Michael J. Stock Option Common stock Option exercise Dispose M No No 0.68 12,700 8.64K 0

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

26.3% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 153 135 +13.3%
Opened positions 45 43 +4.7%
Closed positions 27 30 -10.0%
Increased positions 48 46 +4.3%
Reduced positions 40 26 +53.8%
13F shares
Current Prev Q Change
Total value 378.56M 234.48M +61.4%
Total shares 32.21M 35.46M -9.2%
Total puts 1.94M 2.3M -15.7%
Total calls 2.23M 2.25M -1.1%
Total put/call ratio 0.9 1.0 -14.8%
Largest owners
Shares Value Change
STT State Street 8.49M $51.34M -10.2%
Vanguard 5.48M $33.14M +6.1%
BLK Blackrock 5.42M $32.78M +9.8%
Geode Capital Management 1.44M $8.7M +16.4%
Susquehanna International 1.11M $6.72M +40.1%
PFG Principal Financial Group Inc - Registered Shares 797.06K $4.82M +10.5%
NTRS Northern Trust 737.21K $4.46M +0.2%
Charles Schwab Investment Management 657.92K $3.98M +8.8%
C Citigroup 607.98K $3.68M +433.2%
Thrivent Financial For Lutherans 560.32K $3.39M +2723.3%
Largest transactions
Shares Bought/sold Change
Ra Capital Management 0 -2.74M EXIT
Baker Bros. Advisors 0 -1.4M EXIT
TROW T. Rowe Price 82.54K -1.14M -93.2%
STT State Street 8.49M -958.67K -10.2%
Thrivent Financial For Lutherans 560.32K +540.48K +2723.3%
C Citigroup 607.98K +493.96K +433.2%
BLK Blackrock 5.42M +481.36K +9.8%
Citadel Advisors 498.28K +424.79K +578.0%
Rafferty Asset Management 494.34K +369.04K +294.5%
Susquehanna International 1.11M +317.94K +40.1%
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: Additionally, addressing, afford, appointed, bank, Barker, beginning, binding, boost, caption, Chan, classification, cleared, committee, conserved, contractual, counsel, counterparty, declaratory, deemed, degree, delegated, demand, demanding, denominated, dollar, dosage, eighteen, entirety, exploring, factual, feasibility, forecast, Good, identification, inducing, insignificant, instrument, intramuscular, iv, Kathleen, Lastly, lieu, Lodi, magnitude, marking, mask, maturity, maximize, modified, mutated, NaN, objective, paper, Phillip, pipeline, pivotal, pleading, Practice, prejudice, preliminary, pro, purportedly, realized, referenced, remedy, remove, resumed, retrospective, return, Sanetel, scope, se, serum, single, source, speculative, Stephen, strength, strong, submission, supermajority, sustained, unpredictability, unrealized, version, voluntarily, wearing, withdrew, workplace, wrongful, yen
Removed: absence, accreted, accretion, achievement, agent, agreed, antiviral, assessed, assuming, attractive, avoid, bore, borrowed, cautioned, Center, closing, confidence, contact, converted, covering, cumulative, damage, derived, desire, discontinued, emergency, employee, enabling, enhance, enrolling, entitle, entitling, epidemic, evidenced, evolve, exclusively, expanded, final, financed, formulation, freight, funded, geographic, globally, globe, holder, hospital, impaired, imposed, industry, initiate, interruption, LIBOR, longer, monitoring, multiplied, negatively, Oxford, placement, production, projected, promissory, protected, PRSU, rapid, ratably, receiving, recommended, reconciliation, reimbursable, relationship, rely, repaid, repayable, repayment, restructuring, seasonality, serving, simplify, site, step, suspension, test, travel, ultimate, unit, vesting, volatility, workforce